These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. OMERACT and the clinical evaluation of new therapeutic agents: a bird's eye view. OMERACT Committee. Strand V J Rheumatol; 1993 Mar; 20(3):588-9. PubMed ID: 8478881 [No Abstract] [Full Text] [Related]
3. The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials. Boers M; Tugwell P J Rheumatol; 1993 Mar; 20(3):568-74. PubMed ID: 8478876 [TBL] [Abstract][Full Text] [Related]
4. Reduced joint counts in rheumatoid arthritis clinical trials. American College of Rheumatology Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum; 1994 Apr; 37(4):463-4. PubMed ID: 8147921 [No Abstract] [Full Text] [Related]
5. [Procedure for the evaluation of anti-inflammatory and analgesic agents for the treatment of chronic rheumatoid arthritis: a standard adopted by the Drug Evaluation Committee of the Japan Rheumatism Association]. Shichikawa K; Sugawara S; Azuma T; Aritomi H; Igarashi M; Ichikawa Y; Saito T; Torisu T; Nishioka K; Maoda A Ryumachi; 1983 Aug; 23(4):254-67. PubMed ID: 6364387 [No Abstract] [Full Text] [Related]
6. International consensus on which measures to use in rheumatoid arthritis clinical trials. Boers M Neth J Med; 1993 Aug; 43(1-2):55-8. PubMed ID: 7694164 [No Abstract] [Full Text] [Related]
7. [Indication for a modern therapy of rheumatoid arthritis]. Pappalardo A; Compagno M Clin Ter; 1998; 149(2):135-8. PubMed ID: 9780479 [TBL] [Abstract][Full Text] [Related]
8. [Mefenamic acid in the therapy of rheumatoid arthritis. Clinical experiments and biohumoral control with the double-blind method. (Preliminary observations)]. D'Ingianna E Reumatismo; 1967; 19(3):180-2. PubMed ID: 4890710 [No Abstract] [Full Text] [Related]
9. Important factors in the success and failure of clinical trials (closing remarks). Huskisson EC Agents Actions Suppl; 1980; 7():323-4. PubMed ID: 6941683 [No Abstract] [Full Text] [Related]
10. Minimal disease activity for rheumatoid arthritis: a preliminary definition. Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362 [TBL] [Abstract][Full Text] [Related]
11. Investigational agents for rheumatoid arthritis. Merkel PA; Letourneau EN; Polisson RP Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099 [TBL] [Abstract][Full Text] [Related]
12. [Determination of efficacy of proquazone in chronic rheumatoid arthritis]. Shichikawa K; Azuma T; Ogawa N Ryumachi; 1982 Jun; 22(3):275-83. PubMed ID: 6750811 [No Abstract] [Full Text] [Related]
13. [Results of the test on efficacy of alclofenac in chronic rheumatoid arthritis]. Ryumachi; 1980 Sep; 20(4):305-21. PubMed ID: 6108616 [No Abstract] [Full Text] [Related]
14. Biostatistical aspects in testing anti-inflammatory agents. Rahlfs VW Int Z Klin Pharmakol Ther Toxikol; 1971 Oct; 5(2):187-95. PubMed ID: 5137325 [No Abstract] [Full Text] [Related]
15. [Clinical evaluation of mepirizole (DA-398) in the treatment of chronic rheumatoid arthritis]. Shiokawa Y; Kageyama T; Sakuma A Ryumachi; 1973 Apr; 13(2):206-20. PubMed ID: 4581124 [No Abstract] [Full Text] [Related]
16. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413 [TBL] [Abstract][Full Text] [Related]